Atlas Trials

TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC

Clinical trial NCT03916913 · UNKNOWN

Trial details

NCT number
NCT03916913
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer Metastatic
Start date
2019-01-01
Primary completion
2022-01-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.